This content is from: Patents
FTC sues AbbVie over “baseless patent infringement lawsuits”
The Federal Trade Commission (FTC) has filed a complaint in federal district court charging pharmaceutical companies AbbVie and Besins Healthcare with illegally blocking US consumers’ access to lower-cost versions of the blockbuster drug AndroGel
To access our in-house intelligence please request a trial here.
Read this article – and more – for a 30 day period.
REQUEST ACCESSAre you already an Managing IP subscriber? Login here